Improving hospice care for patients with blood cancers
Official title: HEME-Hospice: An Intervention to improve Hospice Use for Patients with Hematologic Malignancies
Funded at Dana-Farber Cancer Inst · NIH-11089554 · Data updated 2026-11-12
This study is working to improve hospice care for adults with blood cancers by creating a new program that allows them to get important blood transfusions at home, so they can enjoy better end-of-life care in a comfortable and familiar setting.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | June 1, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $643,670 |
| NIH project number | 5R37CA289639-02 |
| Project ID | NIH-11089554 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults diagnosed with blood cancers who are nearing the end of life and require hospice care.
✕Less likely to help
Patients with non-cancer-related terminal illnesses or those who do not have blood cancers may not benefit from this research.
What this research studies
This research aims to enhance hospice care for adults with blood cancers, who often miss out on its benefits. It addresses the barriers that prevent these patients from accessing hospice services, particularly the lack of blood transfusion options. By developing a new model of hospice care called HEME-Hospice, the project seeks to integrate necessary transfusions into home-based hospice settings, allowing patients to receive quality end-of-life care in a familiar environment. The approach includes input from patients and caregivers to ensure it meets their needs effectively.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for patients with blood cancers during their end-of-life care.
How similar studies have gone: Previous research has shown that integrating specialized care models can improve outcomes for patients in hospice, suggesting that this approach may also be effective.
Where this research is happening
-
Dana-Farber Cancer Inst
Boston, United States Active
Researchers
- Principal investigator: Odejide, Oreofe Olukemi — Dana-Farber Cancer Inst
- Study coordinator: Odejide, Oreofe Olukemi
Related research
Other NIH-funded projects on the same topics.
-
Adapting flow cytometry to detect childhood leukemias in Kenya using a single-test screen
A low-cost, blood-based flow cytometry screen in Kenya aims to detect and triage suspected leukemias in children and young adults.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
Why some blood cancer cells survive after treatment by resisting natural killer cells
This work is trying to understand why leftover blood cancer cells in leukemia and multiple myeloma survive treatment by escaping natural killer immune cells.
-
Expanding blood cancer care and research to Brooklyn and Queens
Aimed at bringing more blood cancer care and clinical trials to Brooklyn and Queens to help a diverse patient community.
-
Adapting flow cytometry to detect blood cancers in Kenyan children and young people
A nationwide Kenyan effort will test a cheaper, single-blood-sample screening method using flow cytometry to screen for leukemia in kids and young adults who may have the disease.
-
Next-gen genetic engineering of CD45 to boost CAR-T therapy for blood cancers
A research team is developing a way to make CAR-T cells work for many blood cancers by re-engineering a common blood cell protein called CD45.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.